secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monte Rosa Therapeutics, Inc. (GLUE)
CIK:        0001826457
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001193125-23-264162
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Monte Rosa raises $25M via pre-funded warrant offering at $2.4999 per share
---------------------------------------------------------------------------

- Gross proceeds ~$25M from sale of pre-funded warrants to purchase 10,000,400 shares.
- Offering price $2.4999 per warrant = Oct 25 closing price less $0.0001 exercise price.
- Warrants immediately exercisable at $0.0001; 4.99% beneficial ownership cap (up to 19.99% at holder's election).
- Net proceeds to advance pipeline: MRT-2359, MRT-6160 (VAV1 MGD), and NEK7 program.
- Closing expected on or about Oct 30, 2023, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826457/000119312523264162/0001193125-23-264162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826457/000119312523264162/d512767d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-264162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer